Storia della carriera di Daniela Oniciu
Precedenti posizioni note di Daniela Oniciu
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Direttore Tecnico/Scientifico/R&S | - | 31/12/2023 |
| NEUROBO PHARMACEUTICALS, INC. | Direttore Tecnico/Scientifico/R&S | 01/06/2014 | 01/11/2018 |
| ABIONYX PHARMA | Corporate Officer/Principal | 24/02/2010 | 01/02/2014 |
| PFIZER, INC. | Corporate Officer/Principal | 01/12/2004 | 01/02/2008 |
| ESPERION THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2001 | 01/01/2004 |
| Creative Pharma Advisors LLC | Fondatore | - | - |
BioSavita, Inc.
 BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Direttore operativo | - | - |
Formazione di Daniela Oniciu
| Politehnica University of Bucharest | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Francia | 2 |
| Romania | 2 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chief Operating Officer | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 4 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| OCUPHIRE PHARMA, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
BioSavita, Inc.
BioSavita, Inc. BiotechnologyHealth Technology BioSavita, Inc. operates as a biotechnology company, which develops a technology solution for the development of therapeutic antibodies. It focuses on developing a technology platform based on yeast (saccharomyces cerevisiae) expression systems that accelerate the discovery and development of antibody therapeutics and recombinant proteins. The company was founded by Nalini Ghag-Motwani in 1993 and is headquartered in Plymouth, MI. | Health Technology |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
| Creative Pharma Advisors LLC |
- Borsa valori
- Insiders
- Daniela Oniciu
- Esperienza
